Ozempic is 1,300% More Expensive in the US vs the UK —So the Boss of Novo Nordisk is Being Hauled in Front of Bernie Sanders to Explain Why

Novo Nordisk was the company of 2023, soaring to the mantle of Europe’s most valuable company as its bumper weight-loss-aiding drug Ozempic flew off pharmacy shelves and shaved several inches off consumers’ waistlines. That is, provided its U.S. customers could first cough up the exorbitant price.